Tazarotene 0.015% Cream as a Potential Topical Agent for Management of Ichthyosis in Dorfman-Chanarin Syndrome

Tazarotene 0.015% Cream as a Potential Topical Agent for Management of Ichthyosis in Dorfman-Chanarin Syndrome

Bibliographic Details
Main Authors:	Luana Niculescu, Cristel Ruini, Jerome Srour, Suzanna Salzer, Ines Schönbuchner, Tanja von Braunmühl, Thomas Ruzicka, Ulrich Hohenleutner, Kathrin A. Giehl, Judith Fischer, Andreas Wollenberg
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2019-01-01
Series:	Acta Dermato-Venereologica
Subjects:	tazarotene 0.015% cream Dorfman-Chanarin syndrome ichthyosis optical coherence tomography
Online Access:	https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3087

Similar Items

Chanarin-Dorfman Syndrome with Multi-System Involvement in Two Siblings
by: Seçil Arslansoyu Çamlar, et al.
Published: (2013-03-01)

Dorfman-Chanarin syndrome: An unusual presentation
by: Anupa Mary Job, et al.
Published: (2019-01-01)

Chanarin-Dorfman syndrome treatment with acitretin
by: Reem AlNeyadi, MD, et al.
Published: (2022-06-01)

CHANARIN-DORFMAN SENDROMLU ÇOCUK HASTAYA DENTAL TEDAVİ YAKLAŞIMI: OLGU SUNUMU
by: İrem Can Olgen, et al.
Published: (2016-05-01)

Chanarin Dorfman Syndrome: A Case Report
by: Yasemin Ozkale, et al.
Published: (2015-09-01)

Chanarin Dorfman Sendromu: Olgu Sunumu
by: Yasemin ÖZKALE, et al.
Published: (2015-10-01)

Dorfman-Chanarin syndrome: A rare neutral lipid storage disease
by: Mitra Souvik, et al.
Published: (2010-10-01)

Vacuolated Leukocytes in the Peripheral Blood Smear of a Child with Chanarin-Dorfman Syndrome
by: Arzu Akyay, et al.
Published: (2020-11-01)

A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings
by: Ali Haydar Eskiocak, et al.
Published: (2019-12-01)

Chanarin–Dorfman syndrome: clinical/genetic features and natural history in six Pakistani patients
by: Nadia Waheed, et al.
Published: (2021-08-01)

Case Report: Chanarin-Dorfman Syndrome: A Novel Homozygous Mutation in ABHD5 Gene in a Chinese Case and Genotype-Phenotype Correlation Analysis
by: Bo Liang, et al.
Published: (2022-03-01)

Could “islets of sparing” be a clue for neutral lipid storage disease with ichthyosis in patients with congenital ichthyosiform erythroderma?
by: Filiz Topaloglu Demir, et al.
Published: (2022-01-01)

Recurrent N209* ABHD5 mutation in two unreported families with Chanarin Dorfman Syndrome
by: Daniela Tavian, et al.
Published: (2021-05-01)

Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*)
by: Rita Quelhas da Costa, et al.
Published: (2021-07-01)

Maternal Isodisomy of Chromosome 3 Combined with a <i>De Novo</i> Mutation in the <i>ABHD5</i> Gene Causes Autosomal Recessive Chanarin-Dorfman Syndrome
by: Julia Kopp, et al.
Published: (2021-07-01)

Efficacy and tolerability of 0.1% tazarotene cream and 0.05% tretinoin cream in the treatment of acne vulgaris
by: Mohammad Habibur Rahman, et al.
Published: (2016-07-01)

Transdermal Drug Delivery of Tazarotene: Determining Tazarotene’s Potential in Local Transdermal Therapy
by: Helena Hamzehpour, et al.
Published: (2023-12-01)

Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials
by: Leon H. Kircik, et al.
Published: (2022-05-01)

Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: An observer-blinded randomized controlled study
by: Bijal H Mehta, et al.
Published: (2011-01-01)

Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin
by: Emil A. Tanghetti, et al.
Published: (2023-12-01)

Bowenoid papulosis of the genitalia successfully treated with topical tazarotene : Areport of two cases
by: Shastry Veeranna, et al.
Published: (2009-01-01)

Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology
by: Emil A. Tanghetti, et al.
Published: (2021-05-01)

Low irritation potential of tazarotene 0.045% lotion: Head-to-head comparison to adapalene 0.3% gel and trifarotene 0.005% cream in two studies
by: Zoe D. Draelos
Published: (2023-12-01)

Investigation of Cavitation Noise in Cavitating Flows around an NACA0015 Hydrofoil
by: An Yu, et al.
Published: (2019-09-01)

Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis
by: Essam Bakr Abd El-Aal, et al.
Published: (2019-04-01)

RANS Simulations of Aerodynamic Performance of NACA 0015 Flapped Airfoil
by: Sohaib Obeid, et al.
Published: (2017-01-01)

A Case of Pincer Nail Successfully Treated with Tazarotene 0.1% Gel
by: Laura Vollono, et al.
Published: (2020-05-01)

Comparison of the Efficacy of Tazarotene 0.1% Cream Versus Clindamycin 1% Gel in the Treatment of Acne Vulgaris
by: Afnan Bin Haq, et al.
Published: (2022-11-01)

Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults
by: Reddy V, et al.
Published: (2020-06-01)

Successful treatment of median canaliform nail dystrophy with topical tazarotene foam
by: Eugenie Y. Quan, MD, et al.
Published: (2022-11-01)

Cutaneous ichthyosis secondary to isoniazid
by: Hatim Kouismi, et al.
Published: (2013-04-01)

Recurrent KRT10 Variant in Ichthyosis with Confetti
by: Takuya Takeichi, et al.
Published: (2020-07-01)

CGI-58/ABHD5 is phosphorylated on Ser239 by protein kinase A: control of subcellular localization[S]
by: Anita Sahu-Osen, et al.
Published: (2015-01-01)

CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid acyltransferase
by: Gabriela Montero-Moran, et al.
Published: (2010-04-01)

Efficacy and safety of tafluprost 0.0015% – retrospective analysis of real-world data from the Philippines
by: Tumbocon JA, et al.
Published: (2019-08-01)

Congenital ichthyosis presentation and outcome - A case series
by: Qudsiya A Ansari, et al.
Published: (2023-01-01)

Síndrome Rosai-Dorfman de glándulas salivales Rosai-Dorfman syndrome of the salivary glands
by: Felipe Segundo Fernández Pérez, et al.
Published: (2008-03-01)

Ichthyosis (concept, pathohistology, clinical picture, treatment)
by: Tatyana Gennadyevna Takhtarova, et al.
Published: (2021-07-01)

Harlequin Ichthyosis
by: Ahmad Hashemzadeh, et al.
Published: (2009-02-01)

Harlequin Ichthyosis
by: Hashemzadeh Ahmad, et al.
Published: (2009-04-01)